Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer?
Saved in:
| Title: | Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer? |
|---|---|
| Authors: | Morgans AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: Aliciak_morgans@dfci.harvard.edu., Touya M; Astellas Pharma Inc., Northbrook, IL., El-Chaar N; Astellas Pharma Inc., Northbrook, IL., ElSouda D; Astellas Pharma Inc., Northbrook, IL., Mucha L; Astellas Pharma Inc., Northbrook, IL., Ramaswamy K; Pfizer Inc., New York, NY., Adejumo KL; Cardinal Health, Dublin, OH., Schuler T; Cardinal Health, Dublin, OH., Sharpe J; Cardinal Health, Dublin, OH., Feinberg B; Cardinal Health, Dublin, OH., Asgarisabet P; Cardinal Health, Dublin, OH., Pathak P; Cardinal Health, Dublin, OH., Freedland SJ; Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Durham VA Health Care System, Durham, NC. |
| Source: | Clinical genitourinary cancer [Clin Genitourin Cancer] 2026 Mar; Vol. 24 (2), pp. 102496. Date of Electronic Publication: 2026 Jan 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41604735 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Morgans+AK%22">Morgans AK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: Aliciak&#95;morgans@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Touya+M%22">Touya M</searchLink>; Astellas Pharma Inc., Northbrook, IL.<br /><searchLink fieldCode="AU" term="%22El-Chaar+N%22">El-Chaar N</searchLink>; Astellas Pharma Inc., Northbrook, IL.<br /><searchLink fieldCode="AU" term="%22ElSouda+D%22">ElSouda D</searchLink>; Astellas Pharma Inc., Northbrook, IL.<br /><searchLink fieldCode="AU" term="%22Mucha+L%22">Mucha L</searchLink>; Astellas Pharma Inc., Northbrook, IL.<br /><searchLink fieldCode="AU" term="%22Ramaswamy+K%22">Ramaswamy K</searchLink>; Pfizer Inc., New York, NY.<br /><searchLink fieldCode="AU" term="%22Adejumo+KL%22">Adejumo KL</searchLink>; Cardinal Health, Dublin, OH.<br /><searchLink fieldCode="AU" term="%22Schuler+T%22">Schuler T</searchLink>; Cardinal Health, Dublin, OH.<br /><searchLink fieldCode="AU" term="%22Sharpe+J%22">Sharpe J</searchLink>; Cardinal Health, Dublin, OH.<br /><searchLink fieldCode="AU" term="%22Feinberg+B%22">Feinberg B</searchLink>; Cardinal Health, Dublin, OH.<br /><searchLink fieldCode="AU" term="%22Asgarisabet+P%22">Asgarisabet P</searchLink>; Cardinal Health, Dublin, OH.<br /><searchLink fieldCode="AU" term="%22Pathak+P%22">Pathak P</searchLink>; Cardinal Health, Dublin, OH.<br /><searchLink fieldCode="AU" term="%22Freedland+SJ%22">Freedland SJ</searchLink>; Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Durham VA Health Care System, Durham, NC. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101260955%22">Clinical genitourinary cancer</searchLink> [Clin Genitourin Cancer] 2026 Mar; Vol. 24 (2), pp. 102496. <i>Date of Electronic Publication: </i>2026 Jan 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101260955 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215587673%22">15587673 </searchLink><i>NLM ISO Abbreviation: </i>Clin Genitourin Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41604735 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clgc.2025.102496 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102496 Titles: – TitleFull: Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Morgans AK – PersonEntity: Name: NameFull: Touya M – PersonEntity: Name: NameFull: El-Chaar N – PersonEntity: Name: NameFull: ElSouda D – PersonEntity: Name: NameFull: Mucha L – PersonEntity: Name: NameFull: Ramaswamy K – PersonEntity: Name: NameFull: Adejumo KL – PersonEntity: Name: NameFull: Schuler T – PersonEntity: Name: NameFull: Sharpe J – PersonEntity: Name: NameFull: Feinberg B – PersonEntity: Name: NameFull: Asgarisabet P – PersonEntity: Name: NameFull: Pathak P – PersonEntity: Name: NameFull: Freedland SJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1938-0682 Numbering: – Type: volume Value: 24 – Type: issue Value: 2 Titles: – TitleFull: Clinical genitourinary cancer Type: main |
| ResultId | 1 |
